Inhibition of the conjugation of PABA with glycine in vitro by sulfamoyl benzoic acids, sulfonamides, and penicillins and its relation to tubular secretion

Journal of Pharmaceutical Sciences

Volumn 87, Issue 1, 1998, Pages 101-108

  Ehlert, Christine ^a   Strunz, Hayo ^a   Visser, Klaus ^a   Wiese, Michael ^b   Seydel, Joachim K ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBENZOIC ACID; AMPICILLIN; APALCILLIN; BENZOIC ACID DERIVATIVE; CLOXACILLIN; GLYCINE; MEZLOCILLIN; OXACILLIN; PENICILLIN DERIVATIVE; PENICILLIN G; PROBENECID; SULFACARBAMIDE; SULFADIMETHOXINE; SULFAETHIDOLE; SULFAMETHIZOLE; SULFAMETHOXAZOLE; SULFAMOXOLE; SULFATHIAZOLE; SULFONAMIDE; TICARCILLIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG SYNTHESIS; DRUG TRANSFORMATION; KIDNEY TUBULE; LIVER MICROSOME; NONHUMAN; RAT;

EID: 0031912882     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js9700917     Document Type: Article

References (40)

1. Grantham, J. J.; Chonko, A. M. In The Kidney, 4. Edition; Brenner, B.; Rector, F., Eds.; Saunders: Philadelphia, 1991; pp 483-509.
2. Weiner, I. M. In Handbook of Physiology; Orloff, J.; Berliner, R. W., Eds.; American Physiological Society: Washington, 1973; pp 521-554.
3. Portwich, F.; Büttner, H.; Engelhardt, K. Nierenauscheidung und Eiweissbindung von Sulfonamiden. Klin. Wochenschr. 1963, 41, 447-451.
4. Yacobi, A.; Levy, G. Effect of serum protein binding on sulfisoxazole distribution, metabolism, and excretion in rats. J. Pharm. Sci. 1979, 68, 742-746.
5. Beyer, K. H.; Russo, H. F.; Tilson, E. K.; Miller, A. K.; Verwey, W. F.; Gass, S. R.: Benemid, p-(di-n-propylsulfamyl)-benzoic acid: its renal affinity and its elimination. Am. J. Physiol. 1951, 166, 625-640.
6. Chiang, C.-W. N.; Benet, L. Z.: Dose-dependent kinetics of probenecid in rhesus monkeys - intravenous bolus studies. Pharmacology 1981, 23, 326-336.
7. Cunningham, R. F.; Israeli, Z. H.; Dayton, P. G.: Clinical pharmacokinetics of probenecid. Clin. Pharmakokinet. 1981, 6, 135-151.
8. Garg, S. K.; Panigrahi, D.; Vashisht, R. P.; Tripathi, S. K.; Sharma, P. L. Comparative bioavailability of a combination of ampicillin plus probenecid and ampicillin alone in healthy subjects. Asia Pac. J. Pharmacol. 1992, 7, 33-35.
9. Russel, F. G. M.; Heijn, M. Effect of substituted benzoates on p-aminohippurate transport in dog renal membrane vesicles. Naunyn-Schmiedeberg's Arch. Pharmacol. 1991, 343, 102-107.
10. Seydel, J. K.; Trettin, D.; Cordes, H. P.; Wassermann, O.; Malyusz, M.: Quantitative structure pharmacokinetic relationship derived on antibacterial sulfonamides in rats and its comparison to quantitative structure activity relationship. J. Med. Chem. 1980, 23, 607-613.
11. Seydel, J. K.; Schaper, K.-J. Exceptions in quantitative structure-activity relationships, possible reasons. In Strategy in Drug Research; Keverling Buisman, J. A., Ed.; Elsevier: Amsterdam, 1982; pp 337-354.
12. Ulrich, K. J.; Rumrich, G.; Klöss, S. Contraluminal p-aminohippurate transport in the proximal tubule of the rat kidney. Pflügers Arch. 1987, 409, 547-554.
13. Beyer, K. H. Factors basic to the development of useful inhibitors of renal transport mechanism. Arch. Int. Pharmacodyn. Ther. 1954, 98, 97-117.
14. Beyer, K. H.; Wiebelhaus, V. D.; Tilson, E. K.; Russo, H. F.; Wilhoyte, K. M. "Benemid", p-(di-n-propylsulfamyl)-benzoic acid: inhibition of glycine conjugative reactions. Proc. Soc. Exp. Biol. Med. 1950, 74, 772-775.
15. Beyer, K. H. Funtional characteristics of renal transport mechanisms. Pharmacol. Rev. 1950, 2, 227-280.
16. Cohen, P. P.; McGilvery, R. W. Peptide bond synthesis. I. The formation of p-aminohippuric acid by rat liver slices. J. Biol. Chem. 1946, 166, 261-272.
17. Taggart, J. V. Renal transport of p-aminohippurate labeled with oxigen-18. Science 1956, 124, 401-402.
18. Beyer, K. H.; Painter, R. H.; Wiebelhaus, V. D. Enzymatic factors in renal tubular secretion of phenol red. Am. J. Physiol. 1950, 161, 259-267.
19. Chantrenne, H. J. The requirement for coenzyme A in the enzymatic synthesis of hippuric acid. Biol. Chem. 1951, 189, 227-233.
20. Mahler, H. R.; Wakil, S. J.; Bock, R. M. Studies on fatty acid oxidation. I. Enzymatic activation of fatty acids. J. Biol. Chem. 1953, 204, 453-468.
21. Guarino, A. M.; Conway, W. D.; Fales, H. M. Mass spectral identification of probenecid metabolites in rat bile. Eur. J. Pharmacol. 1969, 8, 244-252.
22. Miller, C. S. U. S. Patent 2 608 507, 1952; Chem. Abstr. 1953, 47, 544a.
23. Goldberg, A. A.; Wragg, A. H. J. p-NN-Dialkyl-sulphamoylbenzoic acid. J. Chem. Soc. 1960, 1408-1409.
24. Sprague, J. M.; Miller, C. S. U. S. Patent 2 608 506, 1952; Chem. Abstr. 1953, 47, 5439h.
25. Albert, A.; Serjeant, E. P. The Determination of Ionization Constants. A Laboratory Manual, 3rd. ed.; Wiley: New York, 1984.
26. Meerdink, D. J.; Wierenga, T.; Russel, R. W.; Young, J. W. Quantitation of p-aminohippuric acid and N-acetyl-p-aminohippuric acid from blood by HPLC. J. Liq. Chromatogr. 1981, 4, 1609-1617.
27. Strunz, H. Entwicklung eines in vitro-Testsystems zur Ermittlung der Hemmung der Konjugation von 4-Aminobenzoesäure mit Glycin durch Sulfamoylbenzoesäure-Derivate und Ableitung von Quantitativen Struktur-Wirkungs-Beziehungen. Dissertation Universität Kiel, 1988.
28. Unger, S. H.; Chiang, G. H. Octanol-physiological buffer distribution coefficients of lipophilic amines by reversed-phase high-performance liquid chromatography and their correlation with biological activity. J. Med. Chem. 1981, 24, 262-270.
29. Tripos Ass., 1699 Hanley Road, St. Louis, MO 63144.
30. Maurhofer, E., Höltje, H.-D. First Workshop on Molecular Modelling, Darmstadt, Germany, May, 1987.
31. McClelland, J. L.; Rumelhart, D. E. Explorations in Parallel Distributed Processing: A Handbook of Models, Programs, and Exercises; MIT: Cambridge, MA 1988.
32. Aoyama, T.; Ichikawa, H. Reconstruction of weight matrixes in neural net works - a method of correlating outputs and inputs. Chem. Pharm. Bull. 1991, 39, 1222-1228.
33. Schröck, C. Die Hemmung der p-Aminobenzoesäure-Glycinierung als mögliches in vitro Modell für die tubuläre Sekretion von Chemotherapeutika. Dissertation Universität Kiel, 1994.
34. Büttner, H.; Portwich, F.; Manzke, E.; Staudt, N. Zur Pharmakokinetik von Sulfonamiden unter pathologischen Bedingungen. Klin. Wochenschr. 1964, 42, 103-108.
35. Seydel, J. K.; Büttner, H.; Portwich, F. Zur Stabilität des 2-Sulfanilamido-4,5-dimethyloxazoles. Klin. Wochenschr. 1965, 43, 1060-1061.
36. Struller, T. Progress in sulfonamide research. Prog. Drug Res. 1968, 12, 389-457.
37. Bergan, T. Pharmacokinetics of mezlocillin in healthy volunteers. Antimicrob. Agents Chemother. 1978, 14, 801-806.
38. Verbist, L.; Tjandramaga, T. B.; Verbesselt, R.; De Schepper, P. J. Mezlocillin pharmacokinetics. Drug Res. 1979, 29, 1962-1966.
39. Lode, H.; Niestrath, U.; Koeppe, P.; Langmaack, H. Pharmakokinetik zweier neuer semisynthesizcher Acylureido-Penicilline: Azlocillin und Mezlocillin. Internat. Symposium Acylureido-Penicilline, Stuttgart, 1978.
40. Bins, J. W.; Mattie, H. Saturation of the tubularsecretion of β-lactam antibiotics. Br. J. Clin. Pharmacol. 1988, 25, 41-50.